Navigation Links
Fuisz Pharma Announces Intent to Divest Strategic Patent for Detection of Opioid Abuse; Seeks Offers for Patent through May 2013
Date:4/22/2013

ticularly advantageous insofar is more deterrence is better.  Moreover, many formulation techniques for crush resistance do not enjoy patent protection.

"Divesting this asset will allow us to better focus on our other drug delivery assets, including the Saturn™ tablet designed for improved esophageal transit and increasingly a focal point of therapeutic and potential product liability concern with regard to unnecessary esophageal excoriation by a whole group of drugs that can cause damage when esophageal transit fails.

"We will accept offers for the '385 through the end of May 2013, but reserve the right to enter into a transaction earlier or otherwise refuse offers.  Interested parties should contact Fuisz Pharma."

Fuisz Pharma is a private pharmaceutical technology company originated by the Fuiszes. The Fuiszes have made substantial contributions in drug delivery including orally dissolving tablets and novel particle coating systems at Fuisz Technologies; inventing and developing thin film drug delivery technologies at Kosmos Pharma and MonoSol Rx, as well as independently developing extruded sheet technology, diagnostics and having extensive experience working with big and specialty pharma. Fuisz Pharma has its headquarters in Miami.  www.fuisz.com.


'/>"/>
SOURCE Fuisz Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Fuisz llc Announces Induction of Richard C. Fuisz, M.D., into Georgetown Universitys 1789 Society.
2. Fuisz Pharma Announces Patent Allowance For New Tablet And Caplet Shapes That Promote Rapid, Reliable Esophageal Transit
3. Pharmagen to Present Strategic Vision for Solving Nations Parenteral Drug Shortage Crisis at 2013 BIO International Convention
4. New PAREXEL Report Defines The Next Generation Of Strategic Partnerships Between CROs And Biopharmaceutical Industry
5. Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance In The United States For Its Previously Announced Acquisition Of Obagi Medical Products, Inc.
6. Statement from the Cystic Fibrosis Foundation on Promising Phase 2 Clinical Trial Results of Kalydeco and VX-661 (Vertex Pharmaceuticals Inc.)
7. The Politics of Pharma: Washington, States, and the Courts Impact on the Industry
8. Biopharmaceutical Managed Care Strength Closely Intertwined with Marketplace Success
9. ADial Pharmaceuticals Announces Agreement With FDA For Phase III Trial Of AD04 For Alcohol Use Disorder In Patients Of Targeted Genotypes
10. Comparison of Biopharmaceutical Industry Between China and India 2013
11. Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable to Conventional Vaccine in Phase I Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... ROCHELLE, N.Y. , March 31, 2015 /PRNewswire-USNewswire/ ... it will be featured in the American Medical ... by ITN Productions. AMGA,s "High Performing ... on the challenges facing the nation,s healthcare system ... Medical Letter is profiled along with other leading ...
(Date:3/31/2015)... -- Accelerated orthodontic treatment will be a featured ... Annual Session, May 15-19, as seven of the ... ® . Manufactured by OrthoAccel ® Technologies, ... a FDA-cleared, Class II medical device that speeds ... percent with just 20 minutes of daily use. ...
(Date:3/31/2015)... DALLAS , March 31, 2015 ... H1 2015" therapeutic market research report of 68 ... its online business intelligence library. The ... information on the therapeutic development for Pemphigus ... therapeutics assessment by drug target, mechanism of action ...
Breaking Medicine Technology:AMGA's High Performing Health News Program Features The Medical Letter 2Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 2Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4
... GSK ) announced today that the U.S. Centers ... Immunization Practices (ACIP) recommended that CERVARIX® [Human papillomavirus bivalent ... girls and young women to protect against cervical pre-cancers ... 18. The ACIP specifically recommended CERVARIX for routine ...
... Accuray Incorporated (Nasdaq: ARAY ), a global ... to establish an America,s region thereby establishing regionalized management ... , The formation of this new Americas region, along ... Japan, gives each region control of revenue and profitability ...
Cached Medicine Technology:CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women 2CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women 3CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women 4Accuray Announces Regionalized Management Strategy for Americas 2Accuray Announces Regionalized Management Strategy for Americas 3
(Date:3/31/2015)... 2015 Bon Secours New York Health ... Schervier Nursing Care Center family last week. The Sisters ... in Yonkers which is scheduled to close later this ... of the Sisters of Charity of New York, the ... to place their Sisters at Schervier Nursing Care Center ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Cosmetic Town, ... the Internet, is proudly enduring adding news to its ... and the consumers of plastic surgery and cosmetic medicine ... user-friendly pages and interconnected sections, the Cosmetic Town community ... addition to the Cosmetic Town site navigation, News and ...
(Date:3/31/2015)... 31, 2015 Karen A. Daley, Ph.D. ... Rivier University’s Commencement ceremony on May 9, ... letters in recognition of her eminent career as a ... a front-line caregiver and senior staff nurse at Brigham ... advancing to leadership roles, including President of the American ...
(Date:3/31/2015)... Indosoft, developer of the Q-Suite call center software suite, announces ... 5.x line. The industry leading contact center ACD ... for more than a decade. By announcing an end of ... fully embrace newer Asterisk features and improve performance. , Q-Suite ... more than a decade. The use of Asterisk, a free, ...
(Date:3/31/2015)... Clinovo, a leading provider of cloud-based ... the premiere voice of Northern California’s Life Science ... , BayBio brings together the collective strength ... productive life science cluster, helping companies grow, connect ... pressing challenges. , “We are thrilled to ...
Breaking Medicine News(10 mins):Health News:Bon Secours New York Health System Welcomes Retired Sisters of Charity to the Family 2Health News:Cosmetic Town is Now Transforming so Consumer can Better Navigate 2Health News:Rivier University to recognize nurse leader, educator and safety advocate at 80th Commencement on May 9th 2Health News:Rivier University to recognize nurse leader, educator and safety advocate at 80th Commencement on May 9th 3Health News:Indosoft Announces End of Life for Asterisk 1.4 Support in Q-Suite 5 Call Center Software 2Health News:Clinovo Joins BayBio Membership Program, The Leading Life Science Association in Northern California 2
... CryoCor, Inc. (Nasdaq:,CRYO), a medical device company focused on ... Brennan, President and Chief,Executive Officer, and Gregory J. Tibbitts, ... Group First Annual Growth Conference in,New York, NY on ... The Grand,Hyatt Hotel. A live Web cast and ...
... Sept. 17 John Brooke, General Manager of,Billian,s ... speaking at Dreamforce ,07 Global Gathering, Salesforce.com,s 5th,Annual ... week. Dreamforce is the ultimate gathering of ... base of Salesforce and AppExchance,users spanning industries, roles ...
... screening may only be modestly accurate, according to researchers from ... North Carolina. In a study that appears in the October ... the usefulness of a scale that asks patients in primary ... to 10 (worst pain). , Universal pain screening ...
... September ... 18th, NEW YORK, Sept. ... meet their millennium,commitment to halve hunger by 2015, the international development agency,ActionAid,s HungerFREE ... table" of the 62nd United Nations General Assembly,Meetings. "The UN is failing ...
... Contrary to concerns that restricting work hours for ... or the residents education, a study in the September ... Surgeons found that limiting work hours does not compromise ... study found that the new model improved overall teaching ...
... ROSEVILLE, Calif., Sept. 17 S.M.A.R.T. Association,Inc. ("SMART"), ... Council,Member" of the Smart Card Alliance, a not-for-profit, ... and,widespread application of Smart Card technology. The ... for smart card,technology, leading industry discussions on the ...
Cached Medicine News:Health News:CryoCor to Present at Maxim Group First Annual Growth Conference in New York 2Health News:Billian's HealthDATA GM Speaking on Dreamforce 07 Panel 2Health News:Rating your pain from 0 to 10 might not help your doctor 2Health News:HungerFREE Campaign Tells UN: 'Put food on the table' 2Health News:Study finds limiting work hours for surgical residents enhances training 2Health News:SMART Association Becomes 'Healthcare Council Member' of Smart Card Alliance 2
... Projector Chart w/ Remote/Controller. Includes ... Adults & Children. Multiple 20/20 slides. ... Programmable feature allows you to customize your ... Halogen Illumination with Long Life. Variety of ...
... The Ultimate in ... Octopus 4.3 stabilizer features ... unmatched stability in the ... 4.3 Stabilizer features the ...
... Inc., the leader in beating heart bypass, ... new Starfish NS device is the first ... patient acceptance of surgical revascularization.,The Starfish NS ... the Multi-Vessel Small Thoracotomy (MVST) procedure without ...
Part of the Octopus System which includes both the Starfish & Octopus3. The Octopus3 Tissue Stabilizer is the pioneering and market-leading suction device....
Medicine Products: